Login / Signup

Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.

Döndü Üsküdar CansuHava Üsküdar TekeSerap IşiksoyCengiz Korkmaz
Published in: International journal of rheumatic diseases (2018)
MF is common in SLE patients. SLE-associated MF as an additional factor for cytopenia in SLE patients may lead to delayed response to appropriate therapy, which may be dependent on the increased grade of BM fibrosis.
Keyphrases
  • systemic lupus erythematosus
  • end stage renal disease
  • bone marrow
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • mesenchymal stem cells
  • rheumatoid arthritis